Paediatric Department, La Rabta Hospital, Jbal Lakhdar, Jebbari, Tunis, Tunisia.
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S313-6. doi: 10.1007/s10545-008-0891-0. Epub 2008 Jul 27.
Fucosidosis (OMIM 230000) is a rare autosomal recessive lysosomal disorder due to deficient α-L-fucosidase activity(EC 3.2.1.51), leading to the accumulation of fucose-containing glycolipids and glycoproteins in various tissues. This study contained the largest ever Tunisian survey of fucosidosis patients, diagnosed during the period 1987-2007. The clinical pictures and outcomes of these patients are compared with literature data. Ten patients (8 boys and 2 girls) from six unrelated families were diagnosed at a mean age of 29 ± 10.3 months. Six of the patients were diagnosed as having the more severe phenotype. The other four cases presented the low progressive phenotype. This distinction was determined by the presence or absence of angiokeratoma and age of death. For all of the patients in our survey, early motor development was more severely delayed than described in the literature. Six patients presented psychomotor decline during the second year of life. Clinical features consist of variable mental retardation (all patients), progressive spastic quadriplegia (6/10 cases), coarse facies (9/10 cases), growth retardation (7/9 cases), visceromegaly (3 cases), angiokeratoma corporis diffusum (4 cases), recurrent bronchopneumonias (all cases), seizures (4 cases) and variable degrees of dysostosis multiplex (all cases). Portal cavernoma, never described in the literature, was observed in one patient. The outcomes were severe in this survey, probably owing to restricted health care; death occurred in 6 of the 10 patients before age 10 years, following recurrent pulmonary infections and neurological deterioration. No intrafamilial variability was noted in the multiplex families. The clinical presentation and outcomes of some of these patients were consistent with the continuous clinical spectrum of severity in fucosidosis attested by most clinical studies.
黏脂贮积症(OMIM 230000)是一种罕见的常染色体隐性溶酶体贮积病,由于α-L-岩藻糖苷酶活性(EC 3.2.1.51)缺乏,导致含有岩藻糖的糖脂和糖蛋白在各种组织中积累。本研究包含了迄今为止在突尼斯进行的最大规模的黏脂贮积症患者调查,这些患者的诊断时间为 1987 年至 2007 年。本研究将这些患者的临床表现和结局与文献数据进行了比较。6 个无亲缘关系的家庭中有 10 名患者(8 名男孩和 2 名女孩),平均诊断年龄为 29±10.3 个月。其中 6 名患者被诊断为更严重的表型,另外 4 名患者表现为低进展性表型。这种区别是由有无血管角皮瘤和死亡年龄决定的。在我们的研究中,所有患者的早期运动发育延迟都比文献中描述的更严重。6 名患者在生命的第二年出现精神运动下降。临床表现包括不同程度的智力迟钝(所有患者)、进行性痉挛性四肢瘫痪(6/10 例)、粗糙面容(9/10 例)、生长迟缓(7/9 例)、内脏肿大(3 例)、弥漫性皮肤血管角皮瘤(4 例)、复发性支气管肺炎(所有患者)、癫痫发作(4 例)和不同程度的多发性骨发育不良(所有患者)。在一名患者中观察到文献中从未描述过的门静脉海绵样变。在本研究中,由于医疗保健受限,结局较为严重,10 名患者中有 6 名在 10 岁之前死亡,死于反复肺部感染和神经恶化。在多态性家族中没有观察到家族内的变异性。这些患者中的一些临床表现和结局与大多数临床研究证明的黏脂贮积症的连续临床严重程度谱一致。